Pancreatic Cancer Research

ResearcherSichuan UniversityActive in the last 2 years

Hong Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2087-3306; OpenAlex author ID A5101821838. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 5

  1. Pancreatic Cancer: Pathogenesis and Clinical Studies. Last author DOI 10.1002/mco2.70162↗
  2. Hydrogel-Based Therapeutics for Pancreatic Ductal Adenocarcinoma Treatment. Last author DOI 10.3390/pharmaceutics15102421↗
  3. Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy. Last author DOI 10.3390/pharmaceutics14102033↗
  4. A novel TRAIL mutant-TRAIL-Mu3 enhances the antitumor effects by the increased affinity and the up-expression of DR5 in pancreatic cancer. First author DOI 10.1007/s00280-018-3658-9↗
  5. Gemcitabine plus S-1 for metastatic pancreatic cancer. Co-author DOI 10.1097/md.0000000000012836↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kexun Zhou · 1 shared paper, 2025 · strength 0.37
  2. Jinlu Liu · 1 shared paper, 2023 · strength 0.26
  3. Qing Zhu · 1 shared paper, 2023 · strength 0.26
  4. Wanting Hou · 1 shared paper, 2022 · strength 0.26
  5. Yi Cheng · 2 shared papers, 2018 · strength 0.20
  6. Hongfeng Gou · 1 shared paper, 2018 · strength 0.12
  7. Ying Huang · 1 shared paper, 2018 · strength 0.09
  8. Min Huang · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.